Company intelligence / Profile preview

MagGenome

Chennai, Tamil Nadu, Indiamaggenome.com ↗

Ownership: Private
Development stage: Commercial

Overview

MagGenome develops patented magnetic nanoparticle-based kits and devices primarily used in DNA/RNA extraction/purification workflows. Their products are widely used by researchers and diagnostic labs to enable high-quality nucleic acid isolation compatible with PCR/qPCR/NGS. The company also has a Natural Medicine division focused on nutraceuticals/cosmeceuticals/veterinary products using advanced screening technologies. They are exploring applications of their core technology in molecular diagnostics and therapeutics but do not have clinical drug candidates.

Therapeutic areas: OtherInfectious Diseases
Modalities: NanoparticleDeviceSmall moleculeBiologic
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on MagGenome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MagGenome.

Explore the full profile